Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

BOSTON SCIENTIFIC CORPORATION

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

WallFlex Biliary Fully Covered (FC) Benign Stricture Study

Phase 3

Completed

Conditions: Biliary Stricture

Interventions: Device: WallFlex Biliary RX Fully Covered Stent System

First Posted Date: 2009-11-17

Last Posted Date: 2020-02-19

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 187

Registration Number: NCT01014390

Locations: 🇦🇺
Westmead Hospital, Westmead, New South Wales, Australia
🇦🇹
Medical University of Vienna, Vienna, Austria
🇧🇪
ULB Erasme Hospital, Brussels, Belgium

and more 10 locations

A Post-Market Study of the AMS AdVance™ Male Sling System for the Treatment of Male Stress Urinary Incontinence

Not Applicable

Completed

Conditions: Stress Urinary Incontinence

Interventions: Device: American Medical Systems (AMS) AdVance™ Male Sling System

First Posted Date: 2009-10-20

Last Posted Date: 2018-10-22

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 114

Registration Number: NCT00998790

Locations: 🇧🇪
Universitaire Ziekenhuisen Leuven, Leuven, Belgium
🇫🇷
Clinique Jules Verne, Nantes, Cedex 3, France
🇫🇷
Hopital Edouard Herriot, Lyon Cedex 03, France

TAXUS Libertē Post Approval Study

Completed

Conditions: Coronary Artery Disease

First Posted Date: 2009-10-19

Last Posted Date: 2015-08-07

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 4199

Registration Number: NCT00997503

Locations: 🇺🇸
Advanced Cardiac Specialists, Mesa, Arizona, United States
🇺🇸
NEA Baptist Memorial Hospital, Jonesboro, Arkansas, United States
🇺🇸
St. Bernard's Medical Center, Jonesboro, Arkansas, United States

and more 79 locations

Clinical Outcome of Pacemaker paTIents According to Pacing Modality and Primary INDications

Completed

Conditions: Bradyarrhythmia

First Posted Date: 2009-09-14

Last Posted Date: 2017-02-01

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 1745

Registration Number: NCT00976482

Locations: 🇩🇪
Katholisches Krankenhaus, St.Johannes Hospital, Hagen, Germany

Longitudinal Surveillance Registry (LSR) of ACUITY Spiral

Terminated

Conditions: Heart Failure

Interventions: Device: ACUITY Spiral Left Ventricular Lead

First Posted Date: 2009-08-10

Last Posted Date: 2019-05-02

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 1308

Registration Number: NCT00955708

Locations: 🇺🇸
Birmingham Heart Clinic, Birmingham, Alabama, United States
🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸
Providence Alaska Medical Center, Anchorage, Alaska, United States

and more 93 locations

Multicenter Automatic Defibrillator Implantation Trial - Reduce Inappropriate Therapy

Not Applicable

Completed

Conditions: Primary Prevention of Sudden Cardiac Arrest

Interventions: Device: Long delay
Device: High rate cutoff
Device: Standard ICD programming

First Posted Date: 2009-07-28

Last Posted Date: 2018-08-08

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 1500

Registration Number: NCT00947310

Locations: 🇺🇸
University of Rochester (Multiple Facilities Participating World Wide), Rochester, New York, United States

Comparative Registry of the PROmus™, ENdeavor™ and CYpher™ Drug Eluting Stents

Completed

Conditions: Percutaneous Coronary Intervention

Interventions: Device: Cardiac Stenting

First Posted Date: 2009-07-02

Last Posted Date: 2017-02-03

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 1934

Registration Number: NCT00930878

Locations: 🇩🇪
Kerckhoff-Klinik GmbH, Bad Nauheim, Hessen, Germany

An Open-label, Single-dose Pilot Study to Evaluate Varisolve® (Polidocanol Endovenous Microfoam (PEM)) 0.125% [0.2%] for Varicose Veins

Phase 2

Completed

Conditions: Varicose Veins

Interventions: Drug: Polidocanol Endovenous Microfoam 0.125%

First Posted Date: 2009-06-26

Last Posted Date: 2021-05-13

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 16

Registration Number: NCT00928421

EPIC Nitinol Stent System in the Treatment of Atherosclerotic Lesions in Iliac Arteries

Phase 3

Completed

Conditions: Iliac Artery Stenosis

Interventions: Device: Epic™ Nitinol Stent System
Drug: Anti-platelet therapy
Drug: Anti-coagulation therapy

First Posted Date: 2009-05-11

Last Posted Date: 2015-05-07

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 125

Registration Number: NCT00896337

Locations: 🇺🇸
St. Joseph's Hospital, Tucson, Arizona, United States
🇺🇸
Brandon Regional Hospital, Brandon, Florida, United States
🇺🇸
Holy Cross Hospital, Fort Lauderdale, Florida, United States

and more 25 locations

Monitoring Pulmonary Artery Pressure by Implantable Device Responding to Ultrasonic Signal (PAPIRUS III)

Completed

Conditions: Heart Failure

First Posted Date: 2009-05-06

Last Posted Date: 2017-02-17

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 18

Registration Number: NCT00893828

Locations: 🇩🇪
University of Cologne, Cologne, Germany

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy